Revealed The Breakthrough Therapy Thats Changing The Face Of Addiction Treatment At Dayton Outpatient Center Main Campus - World Culture

Nasdaq: Lilly's sofetabart mipitecan receives U.S. FDA's Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer INDIANAPOLIS, Jan. 20, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S.

Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ... Lilly's sofetabart mipitecan receives U.S. FDA's Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer